Lupin

LUPIN

Option chain

₹ 2,127.73

- ₹ 47.43

-2.18%

Modeled data

Lupin
Market Sentiment

Timeline	Returns	Volume
Daily	-2.18	5,95,514
Weekly	-4.59%	36,55,255
Monthly	2.12%	1,52,34,560

Lupin
Performance

Timeline	Daily	Weekly	Monthly
LUPIN	-2.18	-4.59%	2.12%
Index	-	-	-
Peer Avg.	-	-3.78%	3.87%

*Avg of index constituents

Lupin
Fundamentals

Timeline	PE	PB	EV/EBIDTA	ROE	ROCE	Div. Yield
LUPIN	37.44	2.36	26.89	-6.42	-3.79	0.53
Index	35.44	5.98	16.81	16.99	18.41	1.19
Peer Avg.	38.60	4.35	13.48	12.96	16.49	0.78

*Avg of index constituents

Lupin
Key Metrics

Metrics	Sales Growth	Profit Growth	ROE	ROCE
FY '21-22	7.33%	-169.04%	-6.42%	-3.79%
FY '20-21	-4.83%	310.56%	8.26%	9.45%
FY '19-20	-1.20%	-98.73%	1.07%	6.20%

Lupin
Shareholding Pattern

Promoters : 46.78%

FII : 14.65%

DII : 27.2%

Public : 11.37%

Others : 0%

Lupin
Profit & Loss

Metrics	Sales	Expenditure	EBITDA	PAT
FY '21-22	14,088.58	13,878.47	427.52	-849.21
FY '20-21	13,109.44	10,803.98	2,438.16	1,242.61
FY '19-20	13,931.11	11,740.13	2,670.45	226.91

All values are in crores

Lupin
Peer Comparison

Metrics	Sales	Expenditure	EBITDA	PAT
LUPIN	14,088.58	13,878.47	427.52	-849.21
BIOCON	4,961.10	4,183.65	1,215.60	532.30
ALKEM	9,732	7,800.36	2,112.91	1,610.79

All values are in crores

Lupin Share Price

Lupin Limited is an Indian pharmaceutical company. The company manufactures, develops and markets a variety of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) worldwide. The company operates in the Cardiovascular, Diabetes, Asthma, Pediatric, CNS, Gastrointestinal, Anti-Infective and Non-Steroidal Anti-Inflammatory drug therapeutic segments and operates in the Anti-Tuberculosis and Cephalosporin segments. The company and its subsidiaries have manufacturing facilities in India, the United States, Mexico and Brazil, and trading and other ancillary and related activities also extend to global markets. Its complex generic portfolio includes Filgrastim, Pegfilgrastim, Etanercept and Albuterol, among others. Its biosimilars include Lupifil (Filgrastim), Lupifil-P (Peg-Filgrastim), and Etanercept.

Lupin FAQs

How to Buy Lupin Share?

To purchase Lupin shares, you can open a Demat & Trading account through a broker or financial institution. Once your account is set up and funded, search for Lupin (ticker symbol: LUPIN) on the trading platform provided by your broker and purchase the shares.

What's Lupin share price today?

The stock price of Lupin as of 20 Sep 2024 is ₹2,127.73

What is the Market Cap of Lupin?

Market capitalisation represents the total market value of a company's outstanding shares. As of 20 Sep 2024, Lupin (ticker symbol: LUPIN) has a market capitalisation of approximately ₹3,43,61,71,09,360.00

What is the PE and PB ratio of Lupin?

Lupin Ltd's price-to-book ratio as of 20 Sep 2024 is 2.3563213, reflecting the market's valuation compared to its asset value. As of 20 Sep 2024, the trailing twelve months P/E (price-to-earnings) ratio is 0, indicating the market values the company at around ₹0.00 for every ₹1 of earnings